293 related articles for article (PubMed ID: 24199952)
1. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
2. CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells.
Chen TJ; Gao F; Yang T; Thakur A; Ren H; Li Y; Zhang S; Wang T; Chen MW
Biochem Biophys Res Commun; 2013 Jul; 437(1):108-13. PubMed ID: 23806693
[TBL] [Abstract][Full Text] [Related]
3. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
4. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
5. Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.
Feng YM; Feng CW; Chen SY; Hsieh HY; Chen YH; Hsu CD
BMC Cancer; 2015 Mar; 15():134. PubMed ID: 25886177
[TBL] [Abstract][Full Text] [Related]
6. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
[TBL] [Abstract][Full Text] [Related]
7. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
9. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
[TBL] [Abstract][Full Text] [Related]
10. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
11. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells.
Wu X; Zhao B; Cheng Y; Yang Y; Huang C; Meng X; Wu B; Zhang L; Lv X; Li J
Toxicol Appl Pharmacol; 2015 Oct; 288(1):74-83. PubMed ID: 26189965
[TBL] [Abstract][Full Text] [Related]
12. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
13. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417
[TBL] [Abstract][Full Text] [Related]
14. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
Sutter AP; Maaser K; Höpfner M; Huether A; Schuppan D; Scherübl H
J Hepatol; 2005 Nov; 43(5):808-16. PubMed ID: 16083991
[TBL] [Abstract][Full Text] [Related]
17. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
[TBL] [Abstract][Full Text] [Related]
18. A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
Fang XY; Zhang H; Zhao L; Tan S; Ren QC; Wang L; Shen XF
Biochimie; 2018 Sep; 152():43-52. PubMed ID: 29960031
[TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
